(Q46842679)

English

Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

convection-enhanced delivery

0 references

Adaptive radiation therapy

0 references

0 references

author name string

Michael A Vogelbaum

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

John H Sampson

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Sandeep Kunwar

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Susan M Chang

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Mark Shaffrey

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Anthony L Asher

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Frederick F Lang

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

David Croteau

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Kristen Parker

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Amy Y Grahn

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Jeffrey W Sherman

11

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

S Rafat Husain

12

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Raj K Puri

13

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

language of work or name

0 references

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

61

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

1031-7; discussion 1037-8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Convection-enhanced delivery of macromolecules in the brain

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Interleukin-13 receptor as a unique target for anti-glioblastoma therapy

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging.

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients.

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malig

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Magnetic resonance imaging and histopathology of cerebral gliomas

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000303199.77370.9E

21 January 2018

Identifiers

10.1227/01.NEU.0000303199.77370.9E

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18091279

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46842679&oldid=2134482845"